Contract HHSD2002017925240003
Rafa Laboratories Ltd · Department Of Health And Human Services · March 13, 2018
Rafa Laboratories Ltd was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on March 13, 2018 for $32.27 million of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ HHSD200201792524I. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 11, 2019.
Contract details
- PIID
- HHSD2002017925240003
- Parent IDIQ
- HHSD200201792524I
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 13, 2018
- Latest action
- January 11, 2019
Description
IGF::OT::IGF ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ
Modification timeline
-
January 11, 2019Mod P00005$0
-
October 1, 2018Mod P00004ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ$0
-
August 22, 2018Mod P00003ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ$0
-
July 26, 2018Mod P00002ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ$0
-
June 5, 2018Mod P00001ATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ$0
-
March 13, 2018Base awardATROPINE SULFATE AUTO-INJECTOR, TRAINING DEVICE, TRAINING - MASTER IDIQ$32.27M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD2002017925240003?
Contract HHSD2002017925240003 is a federal contract awarded to Rafa Laboratories Ltd by Department Of Health And Human Services on March 13, 2018 for $32.27 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 5 times since the base award.
Who won contract HHSD2002017925240003?
Rafa Laboratories Ltd won contract HHSD2002017925240003 from Department Of Health And Human Services.
How much is contract HHSD2002017925240003 worth?
Contract HHSD2002017925240003 has obligated $32.27 million to date, with a total potential value of $35.39 million if all options are exercised.